In particular, we previously reported that Bcl-xL and Bcl-2 increase the NF-kB DNA binding activity with a mechanism dependent to IKKα/β and IKBα phosphorylation in glioblastoma and breast cancer [18, 20, 57]. The gene discussed is BCL2L1; the disease is breast carcinoma.